Back to CR overview

Crane Co (CR): Post-Acquisition Compounding Underway

Published September 4, 202620 min read·TickerFile Research · Crane Co (CR)
ShareXLinkedIn

Crane Company enters the second half of 2026 as a fundamentally re-cast mid-cap diversified industrial. The January closing of the Baker Hughes sensor portfolio and the Optek biopharma optical acquisition transformed the scale and mix of its two retained platforms. Second quarter net sales climbed 25.6% year-over-year. The growth bridge included 5.2% core organic, 19.8% from acquisitions, and a small foreign-exchange tailwind. Operating profit rose materially from a year ago, with adjusted operating margin expanding meaningfully. The headline numbers validate management's portfolio-rationalization thesis. The April 2023 spin of Crane NXT cleared the way for a focused capital-deployment program. The early 2025 divestiture of Engineered Materials recycled significant value into higher-multiple sensor and flow-control assets.

The integration story is moving faster than expected, with management disclosing on July 28 that all four recent acquisitions are outperforming plan. Crane responded by lifting full-year adjusted EPS guidance. The new range sits above the prior band. The new range implies roughly 19% adjusted EPS growth at the midpoint versus 2025. The balance sheet carries $1,098M of total debt against $350M of cash on hand. The figures reflect $1,355M of acquisition cash deployed in the first half of 2026. Net debt to forward adjusted EBITDA tracks in the low-2x area, leaving meaningful headroom for additional bolt-on transactions or shareholder returns. Free cash flow conversion reached a healthy run-rate, supporting the dividend declared for the third quarter of 2026.

The principal offset to the constructive narrative is the expected near-term dilution from acquired goodwill and intangible amortization, which compressed second-quarter Aerospace & Advanced Technologies adjusted operating margin by 80 basis points year-over-year despite a 13.3% core sales print. Investors evaluating the name at roughly 26x forward earnings and 4.5x trailing sales need to weigh two questions. First, does the acquisition pipeline sustain a mid-teens adjusted EPS growth path into 2027. Second, do tariff refunds of $18.7M recognized in the first half represent recurring benefit or a one-time windfall. With a record backlog and a total company order book exceeding $1.8B, visibility into the second half is notably strong for a cyclical industrial. The combination of acquisition momentum and a high-quality backlog underwrites the second-half outlook. The integration of acquired sensing capabilities across both retained segments creates a defensible content-per-platform story that supports the premium valuation.